Log in
NASDAQ:NH

NantHealth Stock Forecast, Price & News

$2.61
-0.08 (-2.97 %)
(As of 09/18/2020 09:33 PM ET)
Add
Compare
Today's Range
$2.58
Now: $2.61
$2.77
50-Day Range
$2.53
MA: $3.49
$5.12
52-Week Range
$0.51
Now: $2.61
$6.39
Volume792,000 shs
Average Volume603,692 shs
Market Capitalization$289.77 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65
NantHealth, Inc., together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice. The company's products include GPS Cancer, a molecular profile that integrates whole genome sequencing of tumor and normal germline samples, as well as whole transcriptome sequencing; GPS Cancer Report, a GPS cancer solution; GPS in rare diseases and chronic illnesses; Liquid GPS, a blood-based molecular test; and Eviti, a decision support solution. It also provides Web-based and mobile software solutions, such as Device Connectivity Suite, a device connectivity and near real-time biometric software and hardware suite; DeviceConX, a device data normalization software; HBox, an Internet of Medical Things and Internet of Things hardware hub; and VitalsConX, a tablet-optimized application. In addition, NantHealth, Inc. offers NaviNet Open, a payer-provider collaboration platform comprising plan central, eligibility and benefit, claims status inquiry, claims management, referral, authorization, document exchange, and AllPayer services; and cloud-based computing, storage, and transport infrastructure-as-a-service solutions. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was founded in 2010 and is headquartered in Culver City, California. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Read More
NantHealth logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.81 out of 5 stars


Industry, Sector and Symbol

Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone310-883-1300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$95.96 million
Book Value($0.52) per share

Profitability

Net Income$-62,760,000.00

Miscellaneous

Employees543
Market Cap$289.77 million
Next Earnings Date11/5/2020 (Estimated)
OptionableOptionable
$2.61
-0.08 (-2.97 %)
(As of 09/18/2020 09:33 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NH News and Ratings via Email

Sign-up to receive the latest news and ratings for NH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NantHealth (NASDAQ:NH) Frequently Asked Questions

How has NantHealth's stock been impacted by Coronavirus?

NantHealth's stock was trading at $1.81 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, NH shares have increased by 44.2% and is now trading at $2.61.
View which stocks have been most impacted by COVID-19
.

When is NantHealth's next earnings date?

NantHealth is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for NantHealth
.

How were NantHealth's earnings last quarter?

NantHealth Inc (NASDAQ:NH) issued its quarterly earnings data on Thursday, August, 6th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.08) by $0.01. The business had revenue of $17.59 million for the quarter, compared to analyst estimates of $18.20 million.
View NantHealth's earnings history
.

Who are some of NantHealth's key competitors?

What other stocks do shareholders of NantHealth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NantHealth investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), AbbVie (ABBV), Gilead Sciences (GILD), Netflix (NFLX), Nantkwest (NK), Novavax (NVAX) and Zynga (ZNGA).

Who are NantHealth's key executives?

NantHealth's management team includes the following people:
  • Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 66)
  • Mr. Ronald Allen Louks, COO & Director (Age 54)
  • Mr. Bob Petrou, Interim Chief Financial Officer (Age 47)
  • Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.
  • Mr. Charles Hunt, VP of Marketing, Communications & User Experience

When did NantHealth IPO?

(NH) raised $91 million in an initial public offering (IPO) on Thursday, June 2nd 2016. The company issued 6,500,000 shares at $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.

What is NantHealth's stock symbol?

NantHealth trades on the NASDAQ under the ticker symbol "NH."

Who are NantHealth's major shareholders?

NantHealth's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Miracle Mile Advisors LLC (0.26%), Nuveen Asset Management LLC (0.09%), Bank of New York Mellon Corp (0.07%), Charles Schwab Investment Management Inc. (0.05%), Jane Street Group LLC (0.05%) and Bridgeway Capital Management Inc. (0.03%).
View institutional ownership trends for NantHealth
.

Which institutional investors are selling NantHealth stock?

NH stock was sold by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc., Miracle Mile Advisors LLC, and Bank of America Corp DE.
View insider buying and selling activity for NantHealth
.

Which institutional investors are buying NantHealth stock?

NH stock was purchased by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Bank of New York Mellon Corp, Charles Schwab Investment Management Inc., Two Sigma Advisers LP, New York State Common Retirement Fund, Jane Street Group LLC, American International Group Inc., and Principal Financial Group Inc..
View insider buying and selling activity for NantHealth
.

How do I buy shares of NantHealth?

Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is NantHealth's stock price today?

One share of NH stock can currently be purchased for approximately $2.61.

How big of a company is NantHealth?

NantHealth has a market capitalization of $289.77 million and generates $95.96 million in revenue each year. The company earns $-62,760,000.00 in net income (profit) each year or ($0.57) on an earnings per share basis. NantHealth employs 543 workers across the globe.

What is NantHealth's official website?

The official website for NantHealth is www.nanthealth.com.

How can I contact NantHealth?

NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]

This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.